The Effect of Medicare’s Physician Quality Reporting System (PQRS) on Quality of Care Bryan Dowd Tami Swenson John Kralewski Robert Kane Jon Christianson.

Slides:



Advertisements
Similar presentations
Nursing Diagnosis: Definition
Advertisements

Factors Affecting Physicians Medicare Service Volume: Beneficiaries Treated and Services per Beneficiary By Jack Hadley and Jim Reschovsky 2005 Academy.
QRUR and Value Modifier:
Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly Findings From the Get With the Guidelines Quality-
1 Case-Control Study Design Two groups are selected, one of people with the disease (cases), and the other of people with the same general characteristics.
FACTORS HINDERING ATTITUDE TO TREATMENT AMONG PATIENTS WITH TYPE-2 DIABETES MELLITUS IN THE NIGER DELTA, NIGERIA by AGOFURE OTOVWE and OYEWOLE OYEDIRAN.
Inappropriate clopidogrel adherence explains stent related adverse outcomes Leonardo Tamariz, MD, MPH University of Miami.
Drug Utilization Review (DUR)
Bree Collaborative Cardiology Report: Appropriateness of Percutaneous Cardiac Interventions (PCI) Bree Collaborative Meeting November 30, 2012.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
Exhibit 1. Medicare Shared Savings Program: Year 1 Performance of Participating Accountable Care Organizations (2013) Source: Centers for Medicare and.
Stanford Prevention Research Center STANFORD SCHOOL OF MEDICINE National Trends in the Prescribing of Anti-Hypertensive Medications Jun Ma, MD, PhD Research.
Lecture 10 Comparison and Evaluation of Alternative System Designs.
11 Populations and Samples.
Chapter 5: Acute Kidney Injury 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
It’s A Success! Achieving Cost-Effective Disease Management in CHF Sherry Shults, RN BSN CIO South Carolina Heart Center.
Readmission and Chronic illness that could benefit from end of life discussions.
Surveillance of Heart Diseases and Stroke Using Centers for Medicare and Medicaid (CMS) Data: A Researcher’s Perspective Judith H. Lichtman, PhD MPH Associate.
Quantitative Research
Using the AOA CAP for CMS’ Physician Quality Reporting Initiative (PQRI) Sharon L. McGill, MPH Director AOA Dept. of Quality and Research November 4, 2009.
DataBrief: Did you know… DataBrief Series ● February 2013 ● No. 37 Medicare Beneficiaries With Severe Mental Illness and Re- Hospitalization Rates In 2010,
Medicare Patients Rights and Better Care Transitions Michael Burgess New York StateWide Senior Action Council, September 13, 2012.
The Evolution of the Physician Compensation Plan: Volume to Value
1 Lotronex ® (alosetron HCl) Tablets Risk-Benefit Issues Victor F. C. Raczkowski, M.D. Director, Division of Gastrointestinal and Coagulation Drug Products.
Research and analysis by Avalere Health Are Medicare Patients Getting Sicker? December 2012.
Presented by Vicki M. Young, PhD October 19,
Clinical Effectiveness of Implantable Cardioverter-Defibrillators Among Medicare Beneficiaries With Heart Failure Adrian F. Hernandez, MD, MHS; Gregg.
Visit us at: The State of Nursing in Florida: Today and in the Future Mary Lou Brunell, RN, MSN Executive Director 10/15/20131.
Preventive Health Care Use in Elderly Uterine Cancer Survivors Division of Health Policy and Management School of Public Health University of Minnesota.
Implementing NICE guidance
1 Long-term Care Vermont’s Approach Individual Supports Unit Division of Disability and Aging Services Department of Disabilities, Aging & Independent.
Customer-Centric Health Intelligence & Solutions Improving Health Outcomes for Medicare Beneficiaries: The Medicare, Medicaid and SCHIP Benefits Improvement.
1 Factors Associated with Regional Variation in Medicare Part D Prescription Drug Plan Participation and Beneficiary Leslie M. Greenwald, Ph.D. Principal.
DIABETES National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
Virginia Chamber of Commerce Health Care Conference Steve Arner SVP / Chief Operating Officer June 6, 2013.
Analyzing NCHS Drug Data Amy B. Bernstein, Sc.D. Presented at the NCHS Board of Scientific Counselors Meeting January 28, 2005 U.S. DEPARTMENT OF HEALTH.
Linda Steffens BSN RN CCRN Stacy Jaeger MS APRN-BC Susan Herrmann MSN RN Kimberly Thomas BSN RN MSM CCRN Katherine Barker MSN RN MSRN CPN Audrey Eggleston.
Quality Measurement and Gender Differences in Managed Care Populations with Chronic Diseases Ann F. Chou Carol Weisman Arlene Bierman Sarah Hudson Scholle.
Measuring changes in physician performance: Is it necessary to adjust for patient characteristics? Hoangmai H. Pham, MD, MPH AcademyHealth Annual Meeting.
Evaluating the Impact of Medicaid Managed Care on Preventive Health Care Use by Children and Adolescents June 24, 2006 Todd Eberly, Ph.D. Child Health.
AAMC Contact: Mary Wheatley December Physician Fee Schedule Value Modifier.
META-ANALYSIS, RESEARCH SYNTHESES AND SYSTEMATIC REVIEWS © LOUIS COHEN, LAWRENCE MANION & KEITH MORRISON.
Oregon's Coordinated Care Organizations: First Year Expenditure and Utilization Authors: Neal Wallace, PhD, Peter Geissert, MPH 1, and K. John McConnell,
Asthma Management and the Allergist: Better Outcomes at Lower Cost.
The Usual Source of Care and Delivery of Preventive Services to Medicare Beneficiaries Academy Health, June 2005 Hoangmai Pham, MD, MPH Deborah Schrag,
How the Independence at Home Demonstration is Good for Home Care HCA Conference Call January 12, 2012.
Copyright © 2013, 2009, and 2007, Pearson Education, Inc. Chapter 10 Comparing Two Groups Section 10.1 Categorical Response: Comparing Two Proportions.
Chapter 5: Acute Kidney Injury 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Vantage Care Positioning System®: Make Your Case with Medicare Spending Data November 2014 avalere.com.
The Role of Health Information Technology in Implementing Disease Management Programs Donald F. Wilson, MD Medical Director Quality Insights of Pennsylvania.
Copyright Medical Group Management Association ® (MGMA ® ). All rights reserved. MACRA: Next steps toward value-based payment in Medicare.
Overcoming the Risk Adjustment Payment Challenge John G. Lovelace, President July 2010.
Overview: APTA Perspectives Alternative Payment Methodology.
Managed Care Nursing Facility Quality Initiatives February 2, 2015.
PRAGMATIC Study Designs: Elderly Cancer Trials
Journal of the American College of Cardiology
Alternative Payment Models in the Quality Payment Program
Quality of Electronic Emergency Department Data: How Good Are They?
Patient Registries and Health Outcomes in Diabetes: A Retrospective Study Nipa Shah, MD1; Fern Webb, PhD1; Liane Hannah, BSH1; Carmen Smotherman, MS2;
Evaluating Policies in Cardiovascular Medicine
Evidence of a Program's Effectiveness in Improving Colorectal Cancer Screening Rates in Federally Qualified Health Centers Robert L. Stephens, PhD, MPH1;
S1316 analysis details Garnet Anderson Katie Arnold
Characteristics of Patients who Choose to Participate in a Comprehensive Medication Review (CMR) Program: Implication for Program Structure and Processes.
Sandra M. Foote Senior Advisor, Chronic Care Improvement June 23, 2005
Encouraging care coordination in FFS Medicare
Abstract Decreased Inappropriate Antibiotic Use Following a Korean National Policy to Prohibit Medication Dispensing by Physicians Sylvia Park, PhD; Stephen.
Market Mover? The Emerging Role of CMS in P4P
Selection of DFU patients and non-DFU controls
The Efficacy of the Teach-Back Method of Education on Readmission Rates in Heart Failure Patients Catherine Lynch Abstract Teach-Back Method The teach-back.
Presentation transcript:

The Effect of Medicare’s Physician Quality Reporting System (PQRS) on Quality of Care Bryan Dowd Tami Swenson John Kralewski Robert Kane Jon Christianson University of Minnesota Robert Coulam Simmons College 1

What is the Physician Quality Reporting System ? Beginning in mid-2007 physicians were given the opportunity to report a new set of quality measures for Medicare beneficiaries under the CMS Physician Quality Reporting System or PQRS. The PQRS measures are developed and approved by organizations such as the National Quality Form (NQF) and National Committee for Quality Assurance (NCQA). Examples of PQRS Measures: Diabetes Mellitus: Hemoglobin A1c Poor Control in Diabetes Mellitus. Developed by the NCQA. A patient aged 18 through 75 years with diabetes mellitus whose most recent hemoglobin A1c was greater than nine percent. Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD. Developed by the American Medical Association-sponsored Physician Consortium on Performance Improvement. A patient aged 18 years and older with a diagnosis of CAD who was prescribed oral antiplatelet therapy. 2

PQRS Measures  PQRS includes both process and outcome measures.  PQRS includes measures indicating both desirable and undesirable outcomes.  Currently, the PQRS reporting system is voluntary – physicians earn an incentive payment simply for reporting PQRS measures. 1.5 percent ( ) increased to 2.0 percent ( ) Later decreased by ACA, to become a penalty for non-participation in 2015  No rewards or penalties tied to the performance on PQRS process or outcome measures 3

An Example of a Part B Claim With PQRS Reports Evaluation and Management Visit Source: 2010 Physician Quality Reporting Initiative Implementation Guide: CMS 4

The Specific Aims of Our Project QUANTITATIVE ANALYSES 1.Is there a relationship between the PQRS measures and the outcome measures (avoidable utilization and cost) in cross sectional data? 2.Was the onset of PQRS reporting associated with a change in the value of the outcome measures? 3.Was the frequency of PQRS reporting associated with a change in the value of the outcome measures? 4.Do these results vary according to the race, ethnicity, or sex of the patient? Do they vary by type of chronic illness? 5

Results So Far – Quantitative Analysis To date, we have results on the second and third aims of our quantitative analysis: 2. Was PQRS associated with a change in outcome measures? 3.Was frequency of PQRS reporting associated with a change in outcome measures? 6

Data  We originally planned to analyze claims data from 2000 to 2010, allowing us to establish a clear time trend for each practice in the pre-PQRS time period.  Budget limitations restricted our beneficiary sample size to 1,999,999 beneficiaries per year for four years of data. Pre-PQRS years: 2005 and 2006 Post-PQRS years: 2008 and was a transition year 7

Revised Sampling Strategy  Drew random sample of TINs from the population of TINs that reported a PQRS measure in either 2008 or = the “cases” or “treatment group” TINs.  Drew a sample of non-reporting TINS matched by zip code and practice size. = the “control” TINs.  Drew equal sized samples of treatment and control TINs from the 2008 and 2009 combined data. 2,744 TINs were present in all four years. 8

Revised Sampling Strategy  Then we: Drew a 100 percent sample of all beneficiaries from treatment and control TINs who met the denominator criteria for at least one PQRS measure for caseloads less than 1000 beneficiaries and Randomly sampled 1000 beneficiaries in TINs with larger than 1000 beneficiary caseloads.  Thus, our results apply only to beneficiaries who were eligible for PQRS reporting. 9

Difference-in-Differences Estimation Y jt = Tin-level outcome variable of interest X jt = a vector of beneficiary and practice characteristics Y200t = 1 if data are from year 200t and 0 otherwise (2005 reference category) PQRS j,t =1 if the practice was a PQRS reporter in either 2008 or 2009 T j,t, 200t = (a) 1 if the data are from a PQRS reporting practice in 2008 or 2009; or (b) various measures of the volume of PQRS reporting (=0 for pre- PQRS years). Errors are clustered by TIN. 10

Conclusions thus far – Quantitative Specific Aims 2 and 3 AIM 2:Was the onset of PQRS reporting associated with a change in the value of the outcome measures? No. There was no statistically significant change in the outcome measures associated with the onset of PQRS reporting. AIM 3: Was the frequency of PQRS reporting associated with a change in the value of the outcome measures? Yes. When the reporting effects are allowed to vary by year, the number of PQRS reports per physician is consistently and negatively associated with ACS admissions and inappropriate ED visits, and negatively associated with risk- adjusted cost in The number of PQRS reports per physician also is consistently and negatively associated with ACS admissions, potentially preventable readmissions, and inappropriate ED visits, but is unrelated to risk-adjusted cost. The proportion of TIN physicians filing PQRS reports was significantly and positively associated with several measures of inappropriate use in

The Specific Aims of Our Project QUALITATIVE ANALYSIS 1.What influences practices participate or not? 2.What problems and opportunities do practices see in PQRS reporting? 3.Is PQRS reporting connected to quality-assurance (QA) efforts of practices and physicians? 4.Do factors identified in these interviews help to explain our outcome measures? 5.Do our interview results suggest ways to improve the PQRS process? 12

Data and Methods for Qualitative Analysis  PQRS implementation issues from the physician group practice’s perspective Analyzes questions of PQRS design, implementation, and process that influence PQRS as a quality-improvement reporting program.  Data from two sources: Eight focus groups with a national sample of 76 medical group practices – arranged with the help of the Medical Group Management Association  47 practices participating in PQRS  29 practices not participating. Interviews at CMS with PQRS managers (coming attraction: October 2012) 13

Participation decisions usually made by administrators – little evidence of physician buy-in and few linkages to other quality assurance (QA) activities. Viewed as a business decision rather than a QA issue, consequently little QA spill over. Wide agreement that the program is not difficult to implement. Wide concern that measures are inadequate – specialist associations need to be more visibly involved for measures to have legitimacy. 14 Conclusions thus far

Conclusions thus far (continued) Practice strategies regarding adoption of innovations trumps most other factors: early adopters vs. wait and see. Only three non-participants said that they might phase out care for Medicare patients when PQRS becomes mandatory. Participating and non-participating sites would like to have a more collaborative relationship with CMS. 15